Bone marrow composition of leukemic (MII and MII/Box) and nonleukemic (wild-type and HoxA9-/-) mice
Mouse type/cell type . | MII . | MII/Hox . | Wild-type . | Hoxa9-/- . |
|---|---|---|---|---|
| Flow cytometry | ||||
| % Gr-1 | 49 ± 6 | 66 ± 6 | ||
| Gr-1+ | 72 ± 3*† | 83 ± 9*‡ | — | — |
| Gr-1- | 20 ± 3*‡ | 31 ± 4*§ | — | — |
| % CD11b | 85 ± 3* | 96 ± 1* | 60 ± 5 | 77 ± 5 |
| % B220 | 9 ± 2* | 11 ± 5* | 23 ± 2 | 28 ± 4 |
| Morphology | ||||
| % blasts | 17 ± 2* | 14 ± 3* | 2 ± 0.4 | 3 ± 0.6 |
| % RBC precursors | 12 ± 1* | 12 ± 4* | 39 ± 3 | 42 ± 5 |
Mouse type/cell type . | MII . | MII/Hox . | Wild-type . | Hoxa9-/- . |
|---|---|---|---|---|
| Flow cytometry | ||||
| % Gr-1 | 49 ± 6 | 66 ± 6 | ||
| Gr-1+ | 72 ± 3*† | 83 ± 9*‡ | — | — |
| Gr-1- | 20 ± 3*‡ | 31 ± 4*§ | — | — |
| % CD11b | 85 ± 3* | 96 ± 1* | 60 ± 5 | 77 ± 5 |
| % B220 | 9 ± 2* | 11 ± 5* | 23 ± 2 | 28 ± 4 |
| Morphology | ||||
| % blasts | 17 ± 2* | 14 ± 3* | 2 ± 0.4 | 3 ± 0.6 |
| % RBC precursors | 12 ± 1* | 12 ± 4* | 39 ± 3 | 42 ± 5 |